Correlation Between Molecular Partners and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Olema Pharmaceuticals, you can compare the effects of market volatilities on Molecular Partners and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Olema Pharmaceuticals.
Diversification Opportunities for Molecular Partners and Olema Pharmaceuticals
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Olema is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Molecular Partners i.e., Molecular Partners and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Molecular Partners and Olema Pharmaceuticals
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 2.04 times more return on investment than Olema Pharmaceuticals. However, Molecular Partners is 2.04 times more volatile than Olema Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 502.00 in Molecular Partners AG on August 25, 2024 and sell it today you would earn a total of 27.00 from holding Molecular Partners AG or generate 5.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Molecular Partners |
| Olema Pharmaceuticals |
Molecular Partners and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Olema Pharmaceuticals
The main advantage of trading using opposite Molecular Partners and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. HCW Biologics | Molecular Partners vs. Scpharmaceuticals | Molecular Partners vs. Milestone Pharmaceuticals |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |